Authors: Bergthorsson, JT Ejlertsen, B Olsen, JH Borg, A Nielsen, KV Barkardottir, RB Klausen, S Mouridsen, HT Winther, K Fenger, K Niebuhr, A Harboe, TL Niebuhr, E

Citation: Jt. Bergthorsson et al., BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age, J MED GENET, 38(6), 2001, pp. 361-368

Authors: Andersson, M Kamby, C Jensen, MB Mouridsen, H Ejlertsen, B Dombernowsky, P Rose, C Cold, S Overgaard, M Andersen, J Kjaer, M

Citation: M. Andersson et al., Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-Operative Group DBCG 82B trial, EUR J CANC, 35(12), 1999, pp. 1659-1666

Authors: Kristensen, B Ejlertsen, B Groenvold, M Hein, S Loft, H Mouridsen, HT

Citation: B. Kristensen et al., Oral clodronate in breast cancer patients with bone metastases: a randomized study, J INTERN M, 246(1), 1999, pp. 67-74

Authors: Bergthorsson, JT Winther, K Fenger, K Niebuhr, A Klausen, S Borg, A Harboe, T Ejlertsen, B Niebuhr, E

Citation: Jt. Bergthorsson et al., Mutations of the BRCA1 and BRCA2 genes in Danish patients diagnosed at young age with multi-centric or bilateral breast cancer, DIS MARKER, 15(1-3), 1999, pp. 94-94